Bayesian modeling and prediction of accrual in multi-regional clinical trials

被引:10
作者
Deng, Yi [1 ]
Zhang, Xiaoxi [2 ]
Long, Qi [1 ]
机构
[1] Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Pfizer Inc, New York, NY USA
关键词
Bayesian modeling; clinical trials; multi-regional trials; nonhomogeneous Poisson process; patient accrual; MULTICENTER TRIALS; EVENT TIMES; RECRUITMENT;
D O I
10.1177/0962280214557581
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In multi-regional trials, the underlying overall and region-specific accrual rates often do not hold constant over time and different regions could have different start-up times, which combined with initial jump in accrual within each region often leads to a discontinuous overall accrual rate, and these issues associated with multi-regional trials have not been adequately investigated. In this paper, we clarify the implication of the multi-regional nature on modeling and prediction of accrual in clinical trials and investigate a Bayesian approach for accrual modeling and prediction, which models region-specific accrual using a nonhomogeneous Poisson process and allows the underlying Poisson rate in each region to vary over time. The proposed approach can accommodate staggered start-up times and different initial accrual rates across regions/centers. Our numerical studies show that the proposed method improves accuracy and precision of accrual prediction compared to existing methods including the nonhomogeneous Poisson process model that does not model region-specific accrual.
引用
收藏
页码:752 / 765
页数:14
相关论文
共 18 条
  • [1] Modelling, prediction and adaptive adjustment of recruitment in multicentre trials
    Anisimov, Vladimir V.
    Fedorov, Valerii V.
    [J]. STATISTICS IN MEDICINE, 2007, 26 (27) : 4958 - 4975
  • [2] [Anonymous], 2010, PHARM STAT, V9, P171
  • [3] [Anonymous], 1978, A Practical Guide to Splines
  • [4] A systematic review of models to predict recruitment to multicentre clinical trials
    Barnard, Katharine D.
    Dent, Louise
    Cook, Andrew
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [5] Barnes K., PHARMA GIANTS RISK R
  • [6] Bayesian adaptive phase II screening design for combination trials
    Cai, Chunyan
    Yuan, Ying
    Johnson, Valen E.
    [J]. CLINICAL TRIALS, 2013, 10 (03) : 353 - 362
  • [7] Predicting event times in clinical trials when treatment arm is masked
    Donovan, JM
    Elliott, MR
    Heitjan, DF
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2006, 16 (03) : 343 - 356
  • [8] Predicting accrual in clinical trials with Bayesian posterior predictive distributions
    Gajewski, Byron J.
    Simon, Stephen D.
    Carlson, Susan E.
    [J]. STATISTICS IN MEDICINE, 2008, 27 (13) : 2328 - 2340
  • [9] Dose-finding in phase I clinical trials based on toxicity probability intervals
    Ji, Yuan
    Li, Yisheng
    Bekele, B. Nebiyou
    [J]. CLINICAL TRIALS, 2007, 4 (03) : 235 - 244
  • [10] Dose-schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation
    Li, Yisheng
    Bekele, B. Nebiyou
    Ji, Yuan
    Cook, John D.
    [J]. STATISTICS IN MEDICINE, 2008, 27 (24) : 4895 - 4913